Mighty Therapeutics
PrivateLast Round
Take Private
Nov 16, 2022
Est. Valuation
$27.58M
Total Funding Raised
$160M
Company Overview
Mighty Therapeutics is a biotechnology company that develops and commercializes novel therapies for rare and age-related diseases involving mitochondrial dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mighty Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Mighty Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Take Private | Nov 16, 2022 | ||||
| Take Private | Aug 1, 2022 | ||||
| Private Placement | Apr 13, 2022 | ||||
| Private Placement | Apr 11, 2022 | ||||
| Debt | Oct 4, 2021 | ||||
Private Placement | Feb 10, 2021 |
Mighty Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| H.C. Wainwright & Co. | IPO |
| Morningside Ventures | Convertible Debt, Corporate Funding |
| Evercore | IPO |
| Atlantis Investment Management | Convertible Debt |
| CMBC Capital Holdings Limited | Convertible Debt |
| Horizon Technology Finance Corporation | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 13, 2020
$20M raised in a private placement round.
Mighty Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mighty Therapeutics's valuation, stock price, and market status.